Capacitive-resistive monopolar radiofrequency appears safe, effective for genitourinary syndrome of menopause
Medical Xpress
February 19, 2026
AI-Generated Deep Dive Summary
A recent study published in *Menopause* highlights the effectiveness of capacitive-resistive monopolar radiofrequency (CRMRF) as a safe and viable treatment option for women experiencing genitourinary syndrome of menopause (GSM). The research found that this therapy significantly improved sexual function and vaginal health in participants, offering a promising solution to symptoms often associated with menopause. This non-invasive approach has shown potential in addressing the physical and emotional challenges faced by many women during this life stage.
Genitourinary syndrome of menopause, commonly referred to as GSM, is characterized by symptoms such as vaginal dryness, dyspareunia (painful intercourse), and reduced sexual satisfaction. These symptoms can have a profound impact on a woman’s quality of life, often leading to emotional distress and relationship challenges. Traditional treatments for GSM have included hormonal therapies and lubricants, but many women seek alternative solutions due to side effects or personal preferences.
The study evaluated the safety and efficacy of CRMRF, which uses radiofrequency energy to target specific areas of the body. This technology is designed to stimulate collagen production, improve blood flow, and enhance tissue repair. In the context of GSM, researchers applied this treatment to the vaginal area, aiming to restore sexual function and vaginal health. The results were encouraging: participants reported significant improvements in lubrication, arousal, and overall sexual satisfaction after just six weeks of therapy.
Beyond its immediate benefits for sexual health, CRMRF has broader implications for women’s wellness. By addressing symptoms like dryness and discomfort, the treatment not only alleviates physical distress but also helps restore confidence and intimacy in relationships. This approach aligns with growing trends toward non-invasive, targeted therapies that address the root causes of menopausal symptoms.
For healthcare
Verticals
healthmedical
Originally published on Medical Xpress on 2/19/2026